Atrys Health, S.A. (BME:ATRY)

Market Cap	232.18M
Revenue (ttm)	226.24M
Net Income (ttm)	-24.59M
Shares Out	75.87M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	33.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,327
Average Volume	87,872
Open	3.000
Previous Close	3.000
Day's Range	2.960 - 3.070
52-Week Range	2.480 - 3.650
Beta	0.61
RSI	63.68
Earnings Date	Mar 28, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.